Patent · US Active

Functional influenza virus-like particles (VLPs)

US9180180B2 · kind B2 · utility

11Cited by
9References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 7, 2014
Grant dateNov 10, 2015
Priority date
Expiry dateJan 7, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2760/16134
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention discloses and claims virus like particles (VLPs) that express and/or contains seasonal influenza virus proteins, avian influenza virus proteins and/or influenza virus proteins from viruses with pandemic potential. The invention includes vector constructs comprising said proteins, cells comprising said constructs, formulations and vaccines comprising VLPs of the inventions. The invention also includes methods of making and administrating VLPs to vertebrates, including methods of inducing substantial immunity to either seasonal and avian influenza, or at least one symptom thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.